You are here

PCSK9 inhibitors

AstraZeneca throws its hat into the oral PCSK9 ring

Pharmaphorum

Wed, 05/29/24 - 11:28 am

PCSK9 inhibitors

Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program

Fierce Biotech

Fri, 08/25/23 - 09:57 am

PCSK9 inhibitors

clinical trials

cardiovascular disease

Cholesterol-focused Esperion loses appetite for oral PCSK9 collab with Serometrix

Fierce Biotech

Tue, 08/1/23 - 11:57 am

Esperion Therapeutics

PCSK9 inhibitors

Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market

Fierce Biotech

Tue, 02/28/23 - 10:03 am

Junshi Biosciences

clinical trials

PCSK9 inhibitors

PCSK9 pipeline shows signs of saturation

EP Vantage

Tue, 09/27/22 - 10:21 am

Ionis Pharmaceuticals

PCSK9 inhibitors

Can A New Cholesterol Drug Restore Merck’s Prominence In Heart Drugs?

Forbes

Tue, 02/1/22 - 10:48 am

PCSK9 inhibitors

Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers

BioSpace

Mon, 11/15/21 - 11:55 pm

PCSK9 inhibitors

Merck looks to ditch the needles with its next-gen oral PCSK9 inhibitor for high cholesterol

Endpoints

Mon, 11/15/21 - 10:57 am

oral PCSK9 inhibitors

PCSK9 inhibitors

Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron

Fierce Pharma

Tue, 06/22/21 - 11:56 am

PCSK9 inhibitors

AZ buys oral PCSK9 cholesterol drug from Dogma Therapeutics

Pharmaforum

Thu, 09/17/20 - 10:38 am

Dogma Therapeutics

PCSK9 inhibitors

ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half

Fierce Biotech

Sat, 03/28/20 - 11:43 pm

PCSK9 inhibitors

MedCo's PCSK9 challenger steals the show at ESC with winning data

Fierce Pharma

Mon, 09/2/19 - 12:27 pm

Medicines Company

PCSK9 inhibitors

European Society of Cardiology

Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha

Fierce Pharma

Wed, 08/28/19 - 10:52 pm

PCSK9 inhibitors

Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst

Fierce Pharma

Tue, 08/27/19 - 12:04 pm

Medicines Company

PCSK9 inhibitors

New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)

Xconomy

Mon, 08/26/19 - 09:49 am

PCSK9 inhibitors

Medicines Company

Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?

Forbes

Mon, 06/10/19 - 10:31 am

The Medicines Company

PCSK9 inhibitors

Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen

Biopharma Dive

Mon, 02/11/19 - 12:23 pm

PCSK9 inhibitors

New drug options, risk factors added to US heart guidelines

Reuters

Sun, 11/11/18 - 09:16 pm

PCSK9 inhibitors

Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi

Fierce Pharma

Thu, 08/9/18 - 03:57 pm

PCSK9 inhibitors

Are These Disappointing Drugs Back on Track to Billions?

Motley Fool

Sun, 05/6/18 - 01:33 pm

PCSK9 inhibitors

Pages